Clinical trialNCT03465592RecruitingPhase 1/PHASE2Interventional

Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment39SarcomaSolid Tumor, AdultSolid Tumor, Childhood

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Nicolas Llosa, MD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Johns Hopkins All Children'S Hospital
St. Petersburg, Florida, United States
Active, not recruiting
Johns Hopkins Hospital
Baltimore, Maryland, United States
Nicolas Llosa, MD
Recruiting
Albert Einstein College of Medicine, Children'S Hospital at Montefiore
The Bronx, New York, United States
David Loeb, MD
Recruiting
New York Medical Center/ Maria Fareri Children'S Hospital
Valhalla, New York, United States
Aliza Gardenswartz, MDMitchell Cario, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 1 May 2018
Primary completion: 31 Jan 2027
Completion: 31 Mar 2029
Last update posted: 5 Feb 2026
Registered enrollment: 39
Registry id: NCT03465592

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.